Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ekso Bionics Holdings Q2 2024 GAAP EPS $(0.13) Beats $(0.14) Estimate, Sales $4.950M Miss $5.171M Estimate

Author: Benzinga Newsdesk | July 29, 2024 04:21pm
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. The company reported quarterly sales of $4.950 million which missed the analyst consensus estimate of $5.171 million by 4.27 percent. This is a 5.25 percent increase over sales of $4.703 million the same period last year.

Posted In: EKSO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist